FRALIFTO
Glaxo Group Limited
Mark For: FRALIFTO® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 88365471 |
| Registration Number | 6133180 |
| Mark Literal Elements | FRALIFTO |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | PUBLICATION AND ISSUE SECTION 2020-05-07 |
| Basis | 44(e) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | Yes |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Merilee J. Arevalo |
| Attorney Docket Number | 82773183 |
| Law Office Assigned | N10 |
| Employee Name | TANNER, MICHAEL R |
Timeline
| 2010-04-19 | Trademark Registered |
| 2019-04-01 | Application Filed |
| 2019-12-31 | Location: PUBLICATION AND ISSUE SECTION |
| 2019-12-31 | Status: Live/Pending |
| 2020-01-01 | Transaction Date |
| 2020-02-04 | Published for Opposition |
| 2020-05-07 | Location: PUBLICATION AND ISSUE SECTION |
| 2020-06-09 | Published |
| 2020-06-09 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
| 2020-08-25 | Trademark Registered |
Trademark Parties (Applicants & Owners)
| Party: |  Glaxo Group Limited |
| Address | 980 Great West Road Brentford, Middlesex UNITED KINGDOM TW89GS |
| Legal Entity Type | Private Company Limited By Shares (prc) |
| Legal Entity State | ENGLAND |
Documents
 Drawing | JPEG | 2019-04-01 |
 TEAS Plus New Application | MULTI | 2019-04-01 |
| XSearch Search Summary | XML | 2019-06-10 |
| Offc Action Outgoing | MULTI | 2019-06-13 |
| Response to Office Action | XML | 2019-12-12 |
| Amendment and Mail Process Complete | MULTI | 2019-12-13 |
| Notation to File | XML | 2019-12-19 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2019-12-31 |
| Notice of Publication | XML | 2020-01-15 |
| Notification Of Notice of Publication | XML | 2020-01-15 |
| OG Publication Confirmation | XML | 2020-02-04 |
| Offc Action Outgoing | XML | 2020-03-26 |
| Offc Action Outgoing | XML | 2020-03-27 |
| Response to Office Action | APPLICATION/XML,IMAGE/JPEG | 2020-04-08 |
| Amendment and Mail Process Complete | MULTI | 2020-04-10 |
| Notation to File | XML | 2020-04-10 |
| TRAM Snapshot of App at Pub for Oppostn | APPLICATION/XML,IMAGE/JPEG | 2020-05-02 |
| Notice of Publication | XML | 2020-05-20 |
| Notification Of Notice of Publication | XML | 2020-05-20 |
| OG Publication Confirmation | APPLICATION/XML | 2020-06-09 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
| GS0051 | Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| PUBLISHED FOR OPPOSITION | 2020-06-09 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-06-09 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-05-20 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-05-01 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-09 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2020-04-08 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-08 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-03-27 | 6325 |
| NON-FINAL ACTION WRITTEN | 2020-03-27 | 78480 |
| NON-FINAL ACTION E-MAILED | 2020-03-27 | 6325 |
| PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2020-03-26 | |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2020-03-26 | 6325 |
| NON-FINAL ACTION WRITTEN | 2020-03-26 | 78480 |
| NON-FINAL ACTION E-MAILED | 2020-03-26 | 6325 |
| ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | 2020-03-20 | |
| PUBLISHED FOR OPPOSITION | 2020-02-04 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-02-04 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-01-15 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-12-30 | |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-12 | 88889 |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-12-12 | |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-12 | 88889 |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-06-13 | 6325 |
| NON-FINAL ACTION WRITTEN | 2019-06-13 | 78480 |
| NON-FINAL ACTION E-MAILED | 2019-06-13 | 6325 |
| ASSIGNED TO EXAMINER | 2019-06-10 | 78480 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2019-04-18 | |
| NEW APPLICATION ENTERED IN TRAM | 2019-04-04 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 FRALIFTO 88365471 not registered Live/Pending |
Glaxo Group Limited 2019-04-01 |
 FRALIFTO 85031940 4453083 Live/Registered |
Glaxo Group Limited 2010-05-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 